Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer
Author:
Affiliation:
1. Department of Surgery; Urology Service; Memorial Sloan-Kettering Cancer Center; New York; NY; USA
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11751.x/fullpdf
Reference13 articles.
1. Cis-diamminedichloroplatinum II in advanced urothelial cancer;Soloway;J Urol,1978
2. Treatment of advanced bladder cancer with cis-diamminedichloroplatinum (II NSC 119875): a pilot study;Merrin;J Urol,1978
3. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists;Lancet,1999
4. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003
5. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines;Stenzl;Eur Urol,2011
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer;American Society of Clinical Oncology Educational Book;2024-06
2. The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium;Urologic Oncology: Seminars and Original Investigations;2024-04
3. One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract;Current Treatment Options in Oncology;2024-02
4. Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial;Journal of Urology;2023-12-28
5. Does Bladder Cancer Subtype Influence Pathologic Complete Response (pCR) and Pelvic Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Response Evaluation After Neoadjuvant Chemotherapy? Pathological Perspective;Clinical Genitourinary Cancer;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3